FIELD: chemistry, immonology.
SUBSTANCE: hybrid protein includes 936 protein sequence from Neisseria meningitides or protein with sequence identical to the mentioned protein sequence by 90% or more, and 741 protein sequence from Neisseria meningitides or protein with sequence identical to the mentioned protein sequence by 90% or more. The sequences can be linked by N- and/or C-end to histidine labels, with or without a linker. Linker is selected out of group of polyglycine linker, histidine labels and GSGGGG linker. A nucleic acid encoding this protein is displayed. Invention also claims composition for treatment and/or prevention of disease caused by Neisseria meningitides bacterium, based on hybrid protein and one or more proteins of the following group: 287, 741, ORF46.1, 961, NH2-A-[X-L-]n-B-COOH, where n=2, X1=287, and X2 is selected out group of: 953, 919, 961, 741. Invention claims application of composition in production of medicine for treatment of disease caused by Neisseria.
EFFECT: efficient treatment and prevention of disease.
13 cl, 5 dwg, 28 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS | 2002 |
|
RU2475495C2 |
HYBRID EXPRESSION OF NEISSERIA PROTEINS | 2001 |
|
RU2304617C2 |
POLYPEPTIDE VACCINES FOR WIDE PROTECTION AGAINST ROWS OF MENINGOCOCCUS GENERATIONS WITH INCREASED VIRULENCE | 2003 |
|
RU2333007C2 |
HETEROLOGOUS EXPRESSION OF NEISSERIA PROTEINS | 2001 |
|
RU2299906C2 |
LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
COMPOSITIONS OF MENINGOCOCCAL VACCINES WITH ADJUVANTS | 2002 |
|
RU2360699C2 |
MULTIPLE VERSIONS OF MENINGOCOCCAL PROTEIN NMB 1870 | 2003 |
|
RU2336091C2 |
COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF INFECTION CAUSED BY MICROORGANISM NEISSERIA | 2000 |
|
RU2244749C2 |
IMPROVEMENT OF BACTERIA OUTER MEMBRANE VESICLE | 2003 |
|
RU2325184C2 |
Authors
Dates
2008-11-27—Published
2002-09-06—Filed